Study casts doubt on virus drug remdesivir
Donnybrook-Bridgetown Mail,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Liverpool City Champion,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Parkes Champion-Post,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
St George & Sutherland Shire Leader ,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Collie Mail,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Wimmera Mail-Times,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Wingham Chronicle,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Islander,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Nyngan Observer,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Examiner,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Murray Valley Standard,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Western Magazine,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Margaret River Mail,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
News story from Bunbury Mail on Friday 16 October 2020
Bunbury Mail,
Study casts doubt on virus drug remdesivir
Busselton Dunsborough Mail,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Singleton Argus,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Campbelltown-Macarthur Advertiser,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Kiama Independent,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Bombala Times,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Advertiser,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Daily Advertiser,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Victor Harbor Times,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Maitland Mercury,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Port Stephens Examiner ,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Blue Mountains Gazette,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
The Bellingen Shire Courier-Sun ,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Barossa and Light Herald,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Manning River Times,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Redland City Bulletin,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Study casts doubt on virus drug remdesivir
Narooma News,
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug…
Gilead questions WHO study that cast doubts on drug's Covid-19 benefits
The Edge Markets,
(Oct 15): Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19…
WHO says remdesivir has little effect in hospitalized Covid-19 — but Gilead calls new data 'inconsistent' with previous findings
End Points,
Max Gelman Associate Editor A new WHO study is throwing cold water on the effectiveness on remdesivir in Covid-19 patients…
Gilead questions WHO study that cast doubts on drug’s Covid-19 benefits
The Hindustan Times,
Home / World News / Gilead questions WHO study that cast doubts on drug’s Covid-19 benefits Gilead Sciences Inc has questioned…
Gilead questions WHO study that cast doubts on drug’s COVID-19 benefits
Sharenet,
* Gilead disputes conclusions from WHO trial * Data suggest little or no benefit on survival * WHO trial found little or no…
Gilead questions WHO study that cast doubts on drug's COVID-19 benefits
Times of India,
Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its COVID-19 drug…
Gilead questions WHO study that cast doubts on drug’s COVID-19 benefits
MetroNews US,
(Reuters) – Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its COVID-1…
Eivind Helle var testperson i WHO-studien Solidarity i kamp mot covid-19
NRK,
Han trodde det var en vanlig influensa. Det vi alle fryktet vårdagene i april, inntok kroppen til Eivind.
Coronaviruset - Nedtur: - Remdesevir virker ikke
Dagbladet,
Gigantstudie slår beina under tidligere studier som viser at det antivirale legemiddelet Remdesivir forkorter syketida og…
WHO: Remdesivir didn't cut hospital stay, mortality for Covid-19
Dhaka Tribune,
File photo: An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg…
Gilead's Remdesivir Ineffective In COVID-19 Patients, WHO Study Finds
Benzinga,
Gilead Sciences, Inc.'s (NASDAQ: GILD ) antiviral drug remdesivir has been found to have "little or no effect on mortality on…
Gilead's Remdesivir Ineffective In COVID-19 Patients, WHO Study Finds
Yahoo! News,
Gilead Sciences, Inc.'s(NASDAQ: GILD) antiviral drugremdesivirhas been found to have "little or no effect on mortality on…
Remdesivir nemá podle WHO vliv na přežití pacientů s covidem
Ceske Noviny,
Lék remdesivir americké společnosti Gilead. Ženeva/Londýn/New York/Praha - Klinické testy v rámci programů Světové zdravotnické…
Remdesivir ne parvient pas à prévenir les décès de Covid-19 lors d’un énorme procès
News 24,
Remdesivir, seul médicament antiviral autorisé pour le traitement du Covid-19 aux États-Unis, ne parvient pas à prévenir les décè…
WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19
Dailyhunt,
After months of planning and testing a handful of repurposed drugs that studies from around the world have found useful in…
Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments
Science/AAAS,
Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
Remdesivir Did Not Cut Hospital Stay Or Mortality In COVID-19 Patients, Finds WHO
Times of India,
Remdesivir, one of first to be used as coronavirus treatment and the only antiviral drug authorized for treatment of COVID-19…
WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19
MSN,
After months of planning and testing a handful of repurposed drugs that studies from around the world have found useful in…
News story from The National on Friday 16 October 2020
The National,
Studi WHO: Remdesivir Tak Bisa Tekan Risiko Kematian Corona
CNN Indonesia,
Jakarta, CNN Indonesia -- Sebuah uji coba besar teranyar menemukan bahwa obat remdesivir tak memberikan pengaruh signifikan…
Remdesivir did not cut hospital stay, mortality
Daily Observer (Bangladesh),
Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival…
Egy óriási kutatás szerint a remdesivir annyira mégsem jó a koronavírus ellen
hvg.hu,
A hatóanyagot mostanra Magyarországon is gyártják, illetve használják a covidos pácienseknél.
Κορωνοϊός : Απογοήτευση από ρεμδεσιβίρη - Ποιο φάρμακο αποδίδει - Ειδήσεις - νέα - Το Βήμα Online
To Vima,
Η θεραπεία με ρεμδεσιβίρη δεν έχει κάποιο ουσιαστικό αποτέλεσμα στην πιθανότητα επιβίωσης ενός ασθενούς με Covid-19 ή στη διάρκει…
Κοροναϊός : Δεν αποδίδει ιδιαίτερα η ρεμδεσιβίρη λέει ο ΠΟΥ – Ποιο φάρμακο αυξάνει την πιθανότητα επιβίωσης - ΤΑ ΝΕΑ
Ta Nea,
tanea.gr > Επιστήμη
WHO के सोलिडैरिटी ट्रायल ने पाया- रेमडेसिविर, HCQ, लोपिनाविर का कोविड मरीजों पर कोई असर नहीं
The Print,
जेनेवा स्थिति विश्व स्वास्थ्य संगठन का हेडक्वार्टर | फोटो: www.who.int Text Size: A- A+ नई दिल्ली: विश्व स्वास्थ्य संगठन द्वारा स…
Study finds remdesivir ineffective in treating Covid patients
The Financial Express,
Gilead Sciences remdesivir had little or no effect on Covid-19 patients' length of hospital stay or chances of survival, a…
WHO Study Finds Remdesivir Didn't Help COVID-19 Patients
NBC4,
A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19…
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
bdnews24,
Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival…
Remdesivir did not cut hospital stay or mortality in COVID-19 patients, WHO says
The Hindu,
The results are from WHO's “Solidarity” trial, which evaluated the effects of four potential drug regimens.
World Health Organization eyes cancer drug in treating COVID-19
ABS-CBN News,
Medical technologists work inside the The Lord’s Grace Medical and Industrial Clinic, a molecular diagnostic laboratory in…
Κοροναϊός : Δεν αποδίδει ιδιαίτερα η ρεμδεσιβίρη, λέει ο ΠΟΥ – Ποιο φάρμακο αυξάνει την πιθανότητα επιβίωσης
in.gr,
Η θεραπεία με ρεμδεσιβίρη δεν έχει κάποιο ουσιαστικό αποτέλεσμα στην πιθανότητα επιβίωσης ενός ασθενούς με Covid-19 ή στη διάρκει…
Covid-19: Remdesivir does not reduce deaths or hospital stay, shows WHO study
Dailyhunt,
The World Health Organization on Thursday said it has found that antiviral drug remdesivir, which has been authorised for Covid-1…
Remdesivir, hydroxychloroquine did not cut hospital stay or mortality in COVID-19 patients: WHO
Zee News (India),
Gilead Sciences Inc`s remdesivir had little or no effect on COVID-19 patients` length of hospital stay or chances of survival…
Η ρεμδεσιβίρη δεν θεραπεύει
Zougla,
Πρώτη καταχώρηση: Παρασκευή, 16 Οκτωβρίου 2020, 08:29 Η θεραπεία με ρεμδεσιβίρη δεν έχει κάποιο ουσιαστικό αποτέλεσμα στην πιθανό…
Study finds Gilead's remdesivir ineffective in treating Covid-19 patients
The Financial Express,
Gilead Sciences remdesivir had little or no effect on Covid-19 patients' length of hospital stay or chances of survival, a…
Covid-19: Remdesivir does not reduce deaths or hospital stay, shows WHO study
Scroll India ,
The World Health Organization on Thursday said it has found that antiviral drug remdesivir, which has been authorised for Covid-1…
News story from The Financial Express (IND) on Friday 16 October 2020
The Financial Express (IND),
Έρευνα: Η ρεμδεσιβίρη δεν μειώνει τη θνησιμότητα από Covid-19
Athina 9.84,
Η θεραπεία με ρεμδεσιβίρη δεν έχει κάποιο ουσιαστικό αποτέλεσμα στην πιθανότητα επιβίωσης ενός ασθενούς με Covid-19 ή στη διάρκει…
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
CNBC TV18,
Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival…
Remdesivir, HCQ, lopinavir
The Print,
New Delhi: The multi-country Solidarity trial anchored by the World Health Organization (WHO) has concluded that none of the…
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients - Times of India
Times of India,
Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival…
News story from Khaleej Times on Friday 16 October 2020
Khaleej Times,
U.S. surpasses 64,000 new coronavirus infections for first time since late July
Washington Post,
Please Note The Washington Post is providing this important information about the coronavirus for free.
Dette skjedde natt til 16. oktober
NRK,
• Trump og Biden møtte til hvert sitt folkemøte • Remdesivir har liten effekt på korona • 184 nye smittetilfeller i Norge Trump…
WHO: Remdesivir did not cut mortality in COVID patients
MSN,
Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival…
Remdesivir did not cut hospital stay or mortality in COVID patients: WHO
Dailyhunt,
Remdesivir did not cut hospital stay or mortality in patients Gilead Sciences Inc's remdesivir had little or no effect on COVID-1…
Remdesivir, hydroxychloroquine did not cut hospital stay or mortality in Covid-19 patients: WHO
The Hindustan Times,
Home / World News / Remdesivir, hydroxychloroquine did not cut hospital stay or mortality in Covid-19 patients: WHO Gilead…
Remdesivir did not cut hospital stay or mortality in COVID patients: WHO
India TV,
Image Source : AP PHOTO Remdesivir did not cut hospital stay or mortality in patients Gilead Sciences Inc's remdesivir had…
Remdesivir Didn't Cut Hospital Stay or Mortality in COVID-19 Patients: WHO Study
The Wire,
Featured image: An ampule of Gilead Sciences COVID-19 antiviral remdesivir. Photo: Ulrich Perrey/Pool via Reuters/File Photo…
Covid-19: Remdesivir did not cut hospital stay or mortality in patients, WHO says
India Today,
Remdesivir, among the first to be used as a treatment for Covid-19, had little or no effect on Covid-19 patients’ length of…
Remdesivir Failed to Prevent Covid-19 Deaths, Hospital Stay of Patients in Huge Trial: WHO
Dailyhunt,
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival…
Big global study finds remdesivir doesn't help Covid-19 patients
MSN,
In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir…
Remdesivir Failed to Prevent Covid-19 Deaths, Hospital Stay of Patients in Huge Trial: WHO
News 18,
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival…
Remdesivir Failed to Prevent Covid-19 Deaths, Hospital Stay of Patients in Huge Trial: WHO
Yahoo! News,
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival…
Big global study finds remdesivir doesn't help COVID-19 patients
CTV News,
In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir…
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
Yahoo! News,
(Reuters) - Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances…
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
Yahoo! News,
View photos (Reuters) - Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay…
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
Times of India,
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients ' length of hospital stay or chances of survival…
Big global study finds remdesivir doesn't help COVID-19 patients
CNN Philippines,
(CNN) — In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug…
Remdesivir did not cut hospital stay or mortality in COVID-19 patients: WHO
livemint,
The study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course…
Big global study finds remdesivir doesn't help Covid-19 patients
CNN News,
(CNN)In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug…
WHO study finds remdesivir didn’t help COVID-19 patients
MyNorthwest.com,
GENEVA (AP) — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help…
WHO data show quartet of therapies fail to reduce COVID death
BioCentury,
Product Development Gilead’s Veklury among repurposed therapies missing mark in SOLIDARITY Oct 16, 2020 | 12:44 AM GMT Data…
Remdesivir did not cut COVID hospital stay or mortality: WHO
Nikkei Asian Review,
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival…
WHO-studie om Remdesivir: Medisinen Trump har fått gir liten effekt mot covid-19
NRK,
Denne artikkelen er over en måned gammel, og kan inneholde utdaterte råd fra myndighetene angående koronasmitten.
Estudo liderado pela OMS em mais de 30 países afirma ineficácia de 4 antivirais contra a Covid-19
G1,
'Solidarity Therapeutics Trial' foi feito em 405 hospitais e com 11.266 pacientes.
Nessun farmaco riduce la mortalit intraospedaliera da Covid-19. Verdetto del Solidarity Therapeutics Trial dell'Oms
Pharmastar Italy,
I risultati provvisori del Solidarity Therapeutics Trial, coordinato dall'Organizzazione Mondiale della Sanit, indicano che i…
EXPERT REACTION: WHO COVID-19 trial finds remdesivir, hydroxychloroquine, lopinavir and interferon don't save lives
Scimex,
The World Health Organisation has published interim results of its Solidarity trial, which investigated whether remdesivir…
ВОЗ: применение ремдесивира, гидроксихлорохина, лопинавира/ритонавира и препаратов интерферона малоэффективно
Azertac,
Баку, 16 октября, АЗЕРТАДЖ В ходе клинического исследования «Solidarity» в рекордные сроки получены убедительные данные в отношен…
WHO study finds remdesivir didn't help COVID-19 patients
Star Tribune,
GENEVA — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help…